Pulse Biosciences, Inc. Effective Income Tax Rate Reconciliation, Other Adjustments, Percent
Pulse Biosciences, Inc. (PLSE) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Percent of -1.10% for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-31.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments · last filed 2025-03-31
- Pulse Biosciences, Inc. effective income tax rate reconciliation, other adjustments, percent for fiscal 2024 was -1.10%.
- Pulse Biosciences, Inc. effective income tax rate reconciliation, other adjustments, percent for fiscal 2023 was -0.80%.
- Pulse Biosciences, Inc. effective income tax rate reconciliation, other adjustments, percent for fiscal 2022 was -0.90%.
- Pulse Biosciences, Inc. effective income tax rate reconciliation, other adjustments, percent for fiscal 2021 was -2.20%.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month |
|---|---|
| 2024-12-31 | -1.10% 10-K · filed 2025-03-31 |
| 2023-12-31 | -0.80% 10-K · filed 2025-03-31 |
| 2022-12-31 | -0.90% 10-K · filed 2024-03-28 |
| 2021-12-31 | -2.20% 10-K · filed 2023-03-31 |
| 2020-12-31 | -0.80% 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |